Two ion-selective sensors of the plastic membrane type were prepared for the determination of oxybutynin hydrochloride (OxCl). They depend on the incorporation of the ion-associates with phosphotungestic acid or phosphomolybdic acid in a PVC matrix. A comparative study is made between their performance characteristics in batch and FIA conditions. The sensors have nearly the same usable concentration, temperature and pH range. They have a wide range of selectivity and can be applied for the determination of the relevant drug with nearly the same precision and accuracy in vitro. Dissolution testing was applied using the sensors; this offers a simple, rapid, cheap way out of sophisticated and high cost instruments used in the pharmacopeial method using HPLC. The investigated drug was determined in its pure and pharmaceutical preparations. The results were accurate and precise, as indicated by the recovery values and coefficients of variation.
Introduction
Oxybutynin is 4-diethylaminobut-2-ynyl2-cyclohexyl-2-hydroxy-2-phenyl-ethanoate. It is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination, by decreasing the muscle spasms of the bladder. [1] [2] [3] There are many methods described in the literature to determine oxybutynin and its metabolite N-desethyloxybutynin in pure state and pharmaceutical preparations, some of these are: chromatographic, like HPLC [4] [5] [6] and GC, 7, 8 spectrophotometric 9 and potentiometric 10 methods. In the present work, two ion-selective membrane sensors were developed for oxybutynin hydrochloride (OxCl) based on the use of the ion association complexes of OxCl with phosphotungestic acid (Ox-PTA) and phosphomolybdic acid (Ox-PMA). The prepared sensors were used to monitor the dissolution profile and the assay of pharmaceutical dosage forms of oxybutynin hydrochloride.
experimental

Reagents and chemicals
All reagents used throughout the work were of analytical-reagent grade and solutions were made with doubly-distilled water. Pure grade oxybutynin hydrochloride (OxCl) was provided by ADWIA company brought from PCAS France. The pharmaceutical preparations: Ditropan ® tablets (5 mg/tab), Sanofi Aventis, Uripan ® tablets 5 mg/tab and Uripan ® syrup 100 mg/100 mg per bottle, ADWIA company, were purchased from local markets. Phosphotungestic acid (PTA) and phosphomolybdic acid (PMA) (Fluka), were used. Dioctylphthalate (DOP), diisononylphthalate (DIP) and dibutylsebacate (DBS) (Fluka) were used as plasticizers. Polyvinyl chloride (PVC) (Fluka), of high relative molecular weight was used for preparing membranes.
Apparatus
The potentiometric measurements in batch mode were carried out using an automatic titrator (Schott tritroline TA 10 plus, Germany). A circulatory thermostat was used to control the temperature of the test solutions (Lauda, Germany). A packed saturated calomel (SCE) (Sentek, UK) was used as an external reference electrode. The electrochemical system can be represented as follows: Ag/AgCl/filling solution/membrane/test solution/KCl salt bridge//SCE. Here the filling solution is a mixture of 1.0 × 10 -3 M solutions of each of the drug and KCl. A flow injection analysis (FIA lab 2500, USA) was used for the FIA measurements. The setup is composed of a 4-channel peristaltic pump and a 6-port 2-way injection valve connected to a Jenway 3510 pH-meter (England); it is interfaced to a strip-chart recorder Model BD111 from Kipp and Zonn (Deft, Netherlands). A wall-jet-cell, providing low dead volume, fast response, good wash characteristics, ease of construction and compatibility with electrodes of various shapes and sizes, was used in flow determinations where a Perspex cup with axially positioned inlet polypropylene tubing is mounted at the sensing surface of the electrode body. 11, 12 The optimized distance between nozzle and the sensing surface of the sensor was 5 mm; this provides the minimum thickness of the diffusion layer and consequently a fast response. Figure 1 represents the flow injection apparatus used in measurements.
Tablet dissolution measurements were made according to the method of the US Pharmacopoeia using an Erwika dissolution device, Germany (USP-type apparatus).
Factors affecting the performance characteristics of the sensors
The potentiometric measurements in batch mode were carried out using a pH-meter Jenway 3510 (England) and a potentiometer (Schott tritroline TA 10 plus, Germany). A circulatory thermostat was used to control the temperature of the test solutions (Lauda, Germany). A packed saturated calomel (SCE) (Sentek, UK) was used as an external reference electrode. The electrochemical system can be represented as follows: Ag/AgCl/filling solution/membrane/test solution/KCl salt bridge//SCE. Here the filling solution is a mixture of 1.0 × 10 -3 M solutions of each of the drug and NaCl. Different compositions of the ion-exchanger to the PVC and plasticizer were prepared as previously described.
14,15 A series of solutions in the concentration range 1.0 × 10 -6 -1.0 × 10 -2 M were measured. The sensor and the reference electrode were immersed in the solution and the e.m.f. value was recorded, after each addition. The values were plotted versus the negative logarithmic value of the drug concentration (p drug).
Different plasticizer contents were tried and the effects of soaking and life span were tested by preconditioning and soaking in 1.0 × 10 -3 M solution of oxybutynin at 25 ± 1 C. A calibration graph was constructed for each sensor after different time intervals till the slope of the calibration graph deviated largely from the Nernstian value and the sensor became out of its usable range; slope of less than 48 mV/concentration decade was reached.
For the determination of the thermal stability of the sensors, calibration graphs were constructed at different test solution temperatures covering the range of 25 -70 C by using a circulating thermostat. The slope, usable concentration range and response time of the sensors corresponding to each temperature were reported.
For FIA measurements, optimizations of the parameters were done by trying samples of different volumes (70 -190 µl) and measuring the response of the sensors at different flow rates (5.0 -10.0 ml/min).
The effect of pH was studied in both batch and FIA conditions and the effects of interfering ions were determined by separate solution and matched potential method. [16] [17] [18] [19] 
Assay of pharmaceutical dosage forms
In batch measurements, the standard addition method was applied. 20 The change in mV reading was recorded for each increment and used to calculate the concentration of the drug in sample solution using the following equation:
Here Cx is the concentration to be determined, Vx the volume of the original sample solution, Vs and Cs the volume and concentration of the standard solution added to the sample to be analyzed, respectively, ΔE is the change in potential after addition of a certain volume of standard solution, and S the slope of the calibration curve. In FIA, a peak height comparison method was used. One series of standard drug solution and another series for tablets and syrup of the same concentrations were prepared, and the peak heights corresponding to these solutions were measured at the optimum FIA parameters related to the sensor used. The percentage recovery can be calculated as the ratio of the peak height of sample to that of an equivalent concentration of standard drug.
For analysis of tablets, 80 tablets were ground and appropriate weights were taken as samples and dissolved in 5 ml 0.1 M HCl and distilled water. The solution was then filtered and used to prepare different concentrations by appropriate dilution. As for syrup, the contents of 3 bottles (each 100 mg/100 ml) were mixed and equivalent volumes to that recorded in the pamphlet of the drug were added using a micro-burette to prepare diluted solutions of different concentrations. For Uripan ® syrup, the maximum concentration to be prepared is 2.5 × 10 -3 M, because the concentration in Uripan ® syrup is 100 mg/100 mg per bottle.
Dissolution test
This was done using an Erwika apparatus according to US pharmacopeia specifications. 13 One tablet of Uripan ® (5 mg/tablet) was placed in the dissolution medium, water, which was maintained at 37.0 ± 0.5 C. The paddle stirrer was rotated at 50 rpm. The oxybutynin selective membrane sensors (Ox-PTA or Ox-PMA) in conjunction with a standard calomel reference electrode dipped in the solution were used as detection system. At time intervals (5 min), the potential values were recorded and the amount of drug released was determined from the calibration graph; then the dissolution profiles were constructed.
results and Discussion
Optimization of the sensor response in batch conditions
All the prepared sensors have very short response times t90 of less than 20 s, according to IUPAC recommendations, and this is the time required by the sensor output to go from the initial value to a percentage (e.g. 90%) of the final value. The composition with 5.0% Ox-PTA and 10% Ox-PMA sensors exhibited the best Nernstian behavior, with slopes of 58.02 and 59.20 mV/concentration decade (after 1 h of soaking in 1.0 × 10 -3 M OxCl) for Ox-PTA and Ox-PMA sensors, respectively, in the working range 1.0 × 10 -5 -1.0 × 10 -2 M and 5.0 × 10 -6 -1.0 × 10 -2 M for Ox-PTA and Ox-PMA sensors, respectively. The best Nernstian response was obtained while using DOP as plasticizer in preparing the sensors compared to the slopes obtained with DBS (52.60 and 55.60 mV/concentration decade) and DIP (52.11 and 52.80 mV/concentration decade), for Ox-PTA and Ox-PMA sensors, respectively; the difference which is due to low solubility or low distribution of ion exchangers in these plasticizers. 21 The effect of soaking of the sensors in 1.0 × 10 -3 M OxCl was studied, it was found that the slopes decrease due to the decrease of the efficiency of the sensors on prolonged soaking, which is may be due to diminished ion exchanger rate of the electro-active species on the membrane gel layer test solution interface. This is responsible for the membrane potential and leaching of the Ox-PTA or Ox-PMA sensors from the external gel layer of the membranes into the bathing solution. 22 The two ion-exchangers were found to have comparable response characteristics and both of them can be successfully used for the assay of the drug. It is also noteworthy to mention that keeping the sensors in dry conditions allows them to be used for up to 90 days.
The effect of changing temperature (20 -70 C) was studied, where the slopes, working concentration ranges, and the standard electrode potentials (E°) of the sensors at each temperature were calculated. The sensors were found to be usable up to temperatures reaching 70 C without noticeable deviation from the ideal Nernstian behavior over the entire temperature range with isothermal coefficient of 1.13 × 10 -3 and 1.12 × 10 -3 V/ C for Ox-PTA and Ox-PMA sensors, respectively, and these values reveal high thermal stability within the studied temperature range (25 -70 C).
Optimization of the flow injection analysis parameters
For the measurements done with FIA, a sample volume of 70 µl was used throughout this work. This gives about 90% of the maximum peak height obtained using a 140-µl loop, but requires a shorter time to recover the base line and allows lower consumption of reagents. 23 A flow rate of 9.0 ml/min was used, which achieves the base line more quickly especially in high concentrations, thus offer in a shorter time of analysis. The dispersion coefficient is determined by measuring the ratio between the peak height obtained at steady state conditions (where the sample acts as carrier) and that at the state of maximum peak height, the maximum dispersion (where the sample is injected in the carrier stream). The dispersion coefficient was found to be 1.33, this value is affected by many parameters such as sample volume, flow rate and carrier composition. 24 Slopes of 67.00 and 68.00 mV/concentration decade were obtained for Ox-PTA and Ox-PMA sensors, respectively, under the above optimum FIA conditions. Figure 2 represents the recordings (a) and their corresponding calibration graphs (b) obtained for Ox-PTA sensor at optimum FIA conditions.
Effect of pH
The results revealed that the change in pH does not affect the potential readings in batch conditions within the range 2.00 -8.00 and 2.00 -7.00 for Ox-PTA and Ox-PMA sensors, respectively. In FIA, the peak heights representing the pH are almost stable in the range 1.00 -6.00 for both Ox-PTA and Ox-PMA sensors, so the sensors can be used safely in these ranges without the need of buffer regulation especially on testing solutions of pharmaceutical preparations that are usually dissolved in acids and have pH values around 2.00 compared to that of the pure drug (pH 5.50).
The potential decrease above these ranges in both conditions can be attributed to the release of free base in the solution, leading to a decrease in the concentration of the detected oxybutynin cation. 25 Figure 3 represents the effect of pH on the response of the Ox-PMA sensor FIA conditions (A) and batch conditions (B), respectively.
Effect of interfering ions
The response of the sensors towards different substances has been checked and the selectivity coefficient E pot Ox,J 2+ was used to evaluate the degree of interference. The response of the sensors towards different substances was checked in both batch and FIA conditions and the values of selectivity coefficients were calculated, as shown in Table 1 . The inorganic cations did not interfere due to the difference in their ionic size, mobilities and permeabilities as compared with the values for oxybutynin. Also, the electrodes showed good tolerance towards sugars, amino acids and urea. This tolerance is mainly attributed to the differences in polarity and lipophilic nature of their molecules from those of the drug under investigation.
Pharmaceutical assay of pharmaceutical dosage forms
Potentiometric determination using standard additions method under batch conditions. The standard addition method was applied by adding small portions of 1.0 × 10 -2 M standard OxCl solution to 50 ml distilled water containing 0.984 -19.697 mg OxCl and used to prepare OxCl sample solutions. The results of the determination of oxybutynin in the parent substance and the pharmaceutical preparations by standard addition method are given in Table 2 . The recovery values ranged from 91.26 -100.71% for Ox-PTA sensor and from 95.87 -100.66% for Ox-PMA sensor; these values are very close to the taken amounts as indicated in the drug pamphlets; this reflects the high accuracy and precision of the sensors for their respective drugs. Potentiometric determination using peak height comparison in FIA conditions. In FIA conditions, the determination of the studied drug in its pharmaceutical preparations was made by preparing a series of solutions of different concentrations from the tablets and syrup. Then the peak heights corresponding to these solutions were measured at a flow rate of 9.0 ml/min using Ox-PTA and Ox-PMA sensors. The obtained peak heights were then compared to those obtained from injecting standard solutions of the same concentrations prepared from pure drugs at the same flow rate and using the same sample loop and other flow conditions. The recovery % can then be calculated as the ratio of the peak heights of the preparations to that of the equivalent concentration of the standard.
Peak heights for solutions prepared from tablets (Ditropan ® , Uripan ® ) and Uripan ® syrup are very close to those of equivalent concentrations of the drug as given in the drug's pamphlets indicating the high accuracy and precision of the determination as shown in Table 3 . Dissolution test. One tablet of Uripan ® (5 mg/tablet) was placed in the dissolution medium, water, which was maintained at 37.0 ± 0.5 C, at time intervals 5 min up to 30 min, and amounts of OxCl released were determined using Ox-PTA and Ox-PMA sensors. After 30 min, Ox-PTA detects the release of 90% of the drug while Ox-PMA detects 92% release; these results meet the specifications of the USP Pharmacopeia which states that not less than 80% of the labeled amount of OxCl should be dissolved in 30 min. 13 Representative dissolution profile for OxCl in Uripan ® tablets determined using the Ox-PMA sensor is presented in Fig. 4 .
This method is simple, rapid, selective, sensitive, and inexpensive; it can measure colored and turbid solutions and does not require any sophisticated instruments or hard to acquire reagents in comparison to the method stated in pharmacopeia using HPLC, which requires taking samples at every time interval, correction of the volume and filtration because HPLC columns and UV detectors will be blocked.
Statistical analysis and validity of the proposed method Precision and accuracy of the method.
The precision and accuracy of the method are expressed as RSD and percent of deviation of the measured concentration (recovery %), and also reproducibility (day to day) was also investigated. Relative standard deviations of less than 2.00% for both Ox-PTA and Ox-PMA sensors were obtained. 26, 27 The limit of detection of the studied sensors (LOD) was calculated, defined as the OxCl concentration corresponding to the intersection of the extrapolation of the linear part of the calibration curve; these were 98 and 9.8 µg for Ox-PTA and Ox-PMA sensors, respectively, while the limit of quantification (LOQ), defined as the last point corresponding to the intersection of the linear part of the calibration curve, was found to be 196 and 984 µg for Ox-PTA and Ox-PMA sensors, respectively. 28 Ruggedness. The ruggedness of the potentiometric method was evaluated by carrying out the analysis using two different instruments on different days. The RSD of less than 1.0% were observed for repetitive measurements in three different day time periods using two different instruments. The results indicate that the method is capable of producing results with high precision. 26 Robustness. Robustness is the quality of being able to withstand stresses, pressures, or changes in procedure or circumstance. A system, organism or design may be said to be "robust" if it is capable of coping well with variations (sometimes unpredictable variations) in its operating environment with minimal damage, alteration or loss of functionality. The robustness of the method was explained by the evaluation of the influence of small variations of the most important procedure variables including pH, potential range and measuring time. The results showed that the method is fairly robust; results are stable, the pH ranges of 2.00 -8.00 and 2.00 -7.00 for Ox-PTA and Ox-PMA sensors, respectively under batch conditions and of 1.00 -6.00 for both Ox-PTA and Ox-PMA sensors under FIA conditions. 26 In order to know if the investigated sensors exhibit any fixed or proportional bias, a simple linear regression for the observed drug concentrations against expected values (4 points) was performed using a computer program (Excel 5). The slopes of the regression lines are near to those of the ideal value of unity. The intercepts were very small, indicating that there is no systematic difference between determined and expected concentrations within the investigated range using the presented method. Table 4 presents the statistical treatment of data obtained for the determination of OxCl using Ox-PTA and Ox-PMA sensors, in comparison with the referenced method. 6 In addition, the proposed method was compared to another potentiometric method used for the determination of oxybutynin. 10 The comparison of the results of the two presented sensors to those in literature as given in Table 5 shows that the sensors proposed in this study have a wide range of selectivity with respect to a large number of inorganic cations, amino acids, urea and sugars, when compared to the other method. The sensors exhibit longer life span (more than 90 days), and have wide stable pH range under both batch and FIA conditions.
The sensors can thus be used for routine analysis and verification in quality assurance during manufacture of oxybutynin and related pharmaceuticals, as well as for checking dissolution. In addition, FIA conditions shorten the time needed for the determination and allow using only small amounts of sample for the detection of the drug in both parent and related pharmaceutical preparations.
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